Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3
1School of Basic Medicine, Nanjing University of Chinese Medicine, Nanjing, China. 718171345@qq.com.
Objective:
To investigate the role of micro ribonucleic acid (miR)-124 in drug resistance of non-small cell lung cancer (NSCLC), and to explore its underlying mechanism.
Materials And Methods:
The expression levels of miR-124 and signal transducer and activator of transcription 3 (STAT3) in maternal A549 cells and cisplatin-resistant A549/DDP cells were detected via quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting. A549 and A549/DDP cells were transfected with miR-124 mimics and miR-124 negative control (NC), respectively. Changes in the expression of STAT3 were detected via qRT-PCR and Western blotting. Meanwhile, the sensitivity of cells transfected with miR-124 mimics to cisplatin was detected via methyl thiazolyl tetrazolium (MTT) assay. The effects of miR-124 on the apoptosis, invasion and metastasis of cells were detected via flow cytometry, wound healing assay and transwell assay, respectively. Moreover, wild-type and mutant-type STAT3 luciferase reporter plasmids were co-transfected with miR-124 mimics or miR-124 NC. Luciferase activity was analyzed using the dual-luciferase reporter gene assay.
Results:
QRT-PCR and Western blotting revealed that the expression level of miR-124 in A549/DDP cells was significantly lower than that of A549 cells. However, the expression level of STAT3 in A549/DDP cells was significantly higher than that of A549 cells. Overexpression of miR-124 remarkably reduced the expression level of STAT3 in A549/DDP cells, increased the sensitivity of A549/DDP cells to cisplatin, and inhibited the invasion and metastasis capacities of cells. In addition, luciferase reporter gene assay demonstrated that miR-124 could negatively regulate the protein expression of STAT3 by binding to its 3'-untranslated region (UTR).
Conclusions:
MiR-124 regulates the sensitivity of NSCLC to cisplatin. Moreover, it inhibits the invasion and metastasis capacities through targeting STAT3, which can serve as a therapeutic target for cisplatin-based chemotherapy resistance of NSCLC.
Insights
MicroRNA-124 (miR-124) is downregulated in non-small cell lung cancer (NSCLC) drug resistance. Restoring miR-124 enhances cisplatin sensitivity and inhibits NSCLC cell invasion and metastasis by targeting STAT3.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Drug resistance in non-small cell lung cancer (NSCLC) poses a significant clinical challenge.
- MicroRNAs (miRNAs) play crucial roles in cancer progression and drug response.
- The specific role of miR-124 in NSCLC chemoresistance remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of microRNA-124 (miR-124) in the development of drug resistance in non-small cell lung cancer (NSCLC).
- To explore the underlying molecular mechanism by which miR-124 influences NSCLC chemoresistance.
- To assess miR-124's potential as a therapeutic target for overcoming cisplatin resistance in NSCLC.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting were used to measure miR-124 and STAT3 expression levels in NSCLC cells.
- Cell lines were transfected with miR-124 mimics to overexpress miR-124.
- Cellular sensitivity to cisplatin, apoptosis, invasion, and metastasis were assessed using MTT assays, flow cytometry, wound healing, and Transwell assays, respectively. Luciferase reporter gene assays were employed to confirm the interaction between miR-124 and STAT3.
Main Results:
- Expression of miR-124 was significantly lower, while signal transducer and activator of transcription 3 (STAT3) expression was significantly higher in cisplatin-resistant NSCLC cells (A549/DDP) compared to sensitive cells (A549).
- Overexpression of miR-124 in A549/DDP cells reduced STAT3 expression, enhanced sensitivity to cisplatin, and inhibited cell invasion and metastasis.
- Luciferase reporter assays confirmed that miR-124 directly targets the 3'-untranslated region (UTR) of STAT3, leading to its negative regulation.
Conclusions:
- MiR-124 plays a critical role in regulating the sensitivity of non-small cell lung cancer (NSCLC) to cisplatin chemotherapy.
- MiR-124 inhibits NSCLC cell invasion and metastasis by targeting and downregulating STAT3 expression.
- STAT3 represents a potential therapeutic target for overcoming cisplatin resistance in NSCLC, with miR-124 serving as a key regulator in this process.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Lung Capacity
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...